Dar Zavain 4
4 · RECURSION PHARMACEUTICALS, INC. · Filed Jun 21, 2023
Insider Transaction Report
Form 4
Dar Zavain
Director
Transactions
- Award
Class A Common Stock
2023-06-16+12,612→ 70,181 total - Award
Stock Option (Right to Buy)
2023-06-16+25,224→ 25,224 totalExercise: $8.92From: 2024-06-16Exp: 2033-06-16→ Class A Common Stock (25,224 underlying)
Holdings
- 36,290
Stock Option (Right to Buy)
Exercise: $6.20From: 2023-06-14Exp: 2032-06-14→ Class A Common Stock (36,290 underlying)
Footnotes (2)
- [F1]Represents a grant of restricted stock units automatically granted pursuant to the Issuer's Outside Director Compensation Policy. The restricted stock units will vest on the earlier of June 16, 2024 or the day prior to the Issuer's 2024 annual meeting of stockholders, subject to Reporting Person's continued service to the Issuer.
- [F2]The shares subject to this option will vest and become exercisable on the earlier of June 16, 2024 or the date of the Issuer's 2024 Annual Meeting of Stockholders, subject to the Reporting Person's continued service to the Issuer.